WHOOP has raised $575 million in a Series G funding round at a valuation of $10.1 billion, as the wearable health company moves to expand its platform globally and push further into what it describes as preventative, personalised healthcare.
The round was led by Collaborative Fund and drew a notably diverse investor base: institutional funds including Qatar Investment Authority and Mubadala Investment Company joined alongside strategic partners Abbott and Mayo Clinic, signalling that the deal is as much about clinical credibility as it is about capital. WHOOP also attracted backing from a number of high-profile athletes, including Cristiano Ronaldo, LeBron James and Rory McIlroy, consistent with the brand’s long association with elite performance.
At the core of WHOOP’s proposition is continuous biometric monitoring through a wrist-worn device, with data fed into AI models trained on more than 24 billion hours of physiological data. The platform tracks sleep, recovery, stress and physical strain, and flags patterns that may indicate emerging health risks. Engagement is unusually high — users check the app multiple times daily — which gives WHOOP a dataset that compounds in value over time.
The company has grown quickly. It now counts more than 2.5 million members globally, with bookings rising 103% in 2025 to reach a $1.1 billion annualised run rate. It also reported positive operating cash flow during the year, an important marker given how capital-intensive scaling a hardware-plus-software health platform tends to be.
WHOOP initially built its user base among professional athletes and serious fitness enthusiasts, but the company is now targeting a much broader market — executives, health-conscious professionals, and consumers more generally who want actionable insight into their wellbeing rather than just step counts and calorie burns. The focus has shifted toward what the company terms “healthspan” — not just how long people live, but how long they live well.
The fresh capital will fund expansion across Europe, the Gulf, Latin America and Asia, as well as continued US growth. WHOOP plans to hire more than 600 people globally, concentrated in research, development and product. The involvement of Abbott and Mayo Clinic as strategic investors suggests the longer-term roadmap involves deeper integration with clinical healthcare rather than remaining a consumer-facing wearable brand.